FDA Adverse Event Malfunction Summary report: N

DEXCOM G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM

MDR report key: 6028368 · Received October 13, 2016

Report

Report Number
3004753838-2016-67198
Event Type
Malfunction
Date Received
October 13, 2016
Date of Event
September 23, 2016
Report Date
September 23, 2016
Manufacturer
DEXCOM, INC.
Product Code
MDS
UDI-DI
00386270000019
PMA / PMN Number
P120005
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

A SENSOR (SERIAL NUMBER (B)(4)/LOT NUMBER 5211764) WAS RETURNED FOR EVALUATION. AN INVESTIGATION WAS UNABLE TO BE PERFORMED BECAUSE THE RETURNED PRODUCT WOULD NOT BE ABLE TO CONFIRM THE REPORTED EVENT OF INACCURACIES. A ROOT CAUSE COULD NOT BE DETERMINED.

Description of Event or Problem · 1

DEXCOM WAS MADE AWARE ON (B)(6) 2016, THAT ON (B)(6) 2016, THERE WERE INACCURACIES BETWEEN THE CONTINUOUS GLUCOSE MONITOR (CGM) AND THE BLOOD GLUCOSE (BG) METER. THE SENSOR WAS INSERTED AT THE ABDOMEN ON (B)(6) 2016. REPORTEDLY, THE PATIENT ENTERED FINGER STICK VALUES DURING LOSS OF SIGNAL. ADDITIONALLY, THE PATIENT WAS TAKING MEDICATION CONTAINING ACETAMINOPHEN. NO ADDITIONAL EVENT OR PATIENT INFORMATION IS AVAILABLE. NO PRODUCT OR DATA WERE PROVIDED FOR EVALUATION. THE REPORTED INACCURACY COULD NOT BE CONFIRMED. A ROOT CAUSE COULD NOT BE DETERMINED. LABELING INDICATES: DO NOT CALIBRATE IF THE OUT OF RANGE SYMBOL SHOWS IN THE STATUS AREA. LABELING INDICATES: MAKE SURE YOU HAVE NOT TAKEN ANY MEDICATIONS CONTAINING ACETAMINOPHEN (SUCH AS TYLENOL).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
678245 DEXCOM G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM CONTINUOUS GLUCOSE MONITOR MDS DEXCOM, INC. 9500-27 5211879 00386270000019

Patients

Seq Age Sex Outcome Treatment
1 37 YR